Mind Medicine (MindMed) Statistics
Total Valuation
MNMD has a market cap or net worth of $625.34 million. The enterprise value is $539.77 million.
| Market Cap | 625.34M |
| Enterprise Value | 539.77M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MNMD has 70.50 million shares outstanding. The number of shares has increased by 26.90% in one year.
| Shares Outstanding | 70.50M |
| Shares Change (YoY) | +26.90% |
| Shares Change (QoQ) | +1.30% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 25.42% |
| Float | 33.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.22 |
| Quick Ratio | n/a |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.30% and return on invested capital (ROIC) is -101.74%.
| Return on Equity (ROE) | -93.30% |
| Return on Assets (ROA) | -67.90% |
| Return on Capital (ROIC) | -101.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.68M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +136.53% in the last 52 weeks. The beta is 2.53, so MNMD's price volatility has been higher than the market average.
| Beta (1Y) | 2.53 |
| 52-Week Price Change | +136.53% |
| 50-Day Moving Average | 8.13 |
| 200-Day Moving Average | 4.75 |
| Relative Strength Index (RSI) | 46.55 |
| Average Volume (30 Days) | 2,258,385 |
Short Selling Information
The latest short interest is 7.23 million, so 10.25% of the outstanding shares have been sold short.
| Short Interest | 7.23M |
| Short Previous Month | 5.87M |
| Short % of Shares Out | 10.25% |
| Short % of Float | 21.83% |
| Short Ratio (days to cover) | 1.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -93.87M |
| Pretax Income | -95.73M |
| Net Income | -95.73M |
| EBITDA | -92.57M |
| EBIT | -95.73M |
| Earnings Per Share (EPS) | -$2.44 |
Balance Sheet
The company has $99.70 million in cash and $14.13 million in debt, giving a net cash position of $85.58 million or $1.21 per share.
| Cash & Cash Equivalents | 99.70M |
| Total Debt | 14.13M |
| Net Cash | 85.58M |
| Net Cash Per Share | $1.21 |
| Equity / Book Value | 78.13M |
| Book Value Per Share | 1.11 |
| Working Capital | 71.63M |
Cash Flow
| Operating Cash Flow | -64.37M |
| Capital Expenditures | n/a |
| Free Cash Flow | -64.37M |
| FCF Per Share | -$1.64 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.90% |
| Shareholder Yield | -26.90% |
| Earnings Yield | -15.31% |
| FCF Yield | -10.29% |
Analyst Forecast
The average price target for MNMD is $30.17, which is 240.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.17 |
| Price Target Difference | 240.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |